Long-term outcome of patients treated with antithyroid drugs, radioactive iodine or surgery for persistent or relapsed Graves' disease.
Xiaodong LiuCarlos King-Ho WongWendy W L ChanEric H M TangYu Cho WooShirley Y W LiuCindy L K LamBrian Hung-Hin LangPublished in: The British journal of surgery (2022)
Patients who underwent surgery for persistent or relapsed Graves' disease had lower risks of all-cause mortality and analysed morbidities. The 10-year cumulative healthcare cost in the surgery group was lowest among the three treatment alternatives.
Keyphrases
- minimally invasive
- coronary artery bypass
- healthcare
- acute lymphoblastic leukemia
- acute myeloid leukemia
- end stage renal disease
- surgical site infection
- diffuse large b cell lymphoma
- multiple myeloma
- newly diagnosed
- chronic kidney disease
- ejection fraction
- hodgkin lymphoma
- prognostic factors
- magnetic resonance imaging
- patient reported outcomes
- computed tomography
- social media
- human health
- health insurance